The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-N,N-diethyl-5,10-dihydroindeno[1,2-b]indole-10-carboxamide ID: ALA2377327
PubChem CID: 71579683
Max Phase: Preclinical
Molecular Formula: C20H20N2O
Molecular Weight: 304.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCN(CC)C(=O)C1c2ccccc2-c2[nH]c3ccccc3c21
Standard InChI: InChI=1S/C20H20N2O/c1-3-22(4-2)20(23)18-13-9-5-6-10-14(13)19-17(18)15-11-7-8-12-16(15)21-19/h5-12,18,21H,3-4H2,1-2H3
Standard InChI Key: XTARLFSAXRGTDF-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
13.7175 -11.9772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7163 -12.7967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4244 -13.2057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4226 -11.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1312 -11.9736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1360 -12.7922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9160 -13.0406 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9083 -11.7161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3952 -12.3741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3837 -11.0498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1643 -11.2959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1708 -12.1116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8794 -12.5121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5820 -12.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5715 -11.2791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8623 -10.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1228 -10.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6643 -9.6607 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3220 -10.1099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.4650 -9.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4049 -8.8858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9464 -8.2737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0065 -9.2116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
9 12 1 0
11 10 1 0
10 8 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
17 18 1 0
17 19 2 0
10 17 1 0
18 20 1 0
18 21 1 0
21 22 1 0
20 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 304.39Molecular Weight (Monoisotopic): 304.1576AlogP: 4.15#Rotatable Bonds: 3Polar Surface Area: 36.10Molecular Species: NEUTRALHBA: 1HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.03CX Basic pKa: ┄CX LogP: 3.33CX LogD: 3.33Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.78Np Likeness Score: -0.36
References 1. O'Shea D, Ahmad R, Årstad E, Avory M, Chau WF, Durrant C, Hirani E, Jones PA, Khan I, Luthra SK, Mantzilas D, Morisson-Iveson V, Passmore J, Robins EG, Shan B, Wadsworth H, Walton S, Zhao Y, Trigg W.. (2013) Exploration of the structure-activity relationship of a novel tetracyclic class of TSPO ligands-potential novel positron emitting tomography imaging agents., 23 (8): [PMID:23489633 ] [10.1016/j.bmcl.2013.02.057 ]